Hypoxia‐inducible factor‐2α (HIF‐2α), but not HIF‐1α, is essential for hypoxic induction of class III β‐tubulin expression in human glioblastoma cells

Glioblastoma multiforme (GBM) is the deadliest form of primary brain cancer. Several reports have indicated aberrant levels of βIII‐tubulin (βIII‐t) in human GBM. βIII‐t overexpression was linked to increasing malignancy in glial tumors and described to determine the onset of resistance to chemother...

Full description

Saved in:
Bibliographic Details
Published inThe FEBS journal Vol. 281; no. 23; pp. 5220 - 5236
Main Authors Bordji, Karim, Grandval, Alexandra, Cuhna‐Alves, Leilane, Lechapt‐Zalcman, Emmanuèle, Bernaudin, Myriam
Format Journal Article
LanguageEnglish
Published England Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies 01.12.2014
Wiley
Subjects
Online AccessGet full text
ISSN1742-464X
1742-4658
1742-4658
DOI10.1111/febs.13062

Cover

Abstract Glioblastoma multiforme (GBM) is the deadliest form of primary brain cancer. Several reports have indicated aberrant levels of βIII‐tubulin (βIII‐t) in human GBM. βIII‐t overexpression was linked to increasing malignancy in glial tumors and described to determine the onset of resistance to chemotherapy. Furthermore, a linkage was suggested between the induction of βIII‐t expression and hypoxia, a hallmark of GBM. We investigated the role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α in the regulation of the βIII‐t gene (TUBB3) in GBM cells cultured in either normoxia or hypoxia. We report for the first time that HIF‐2α, but not HIF‐1α, is involved in hypoxia‐induced βIII‐t expression in GBM cells. By gene‐reporter experiments and site‐directed mutagenesis, we found that two overlapping hypoxia response elements located in the 3′ UTR of the gene were involved in the activation of TUBB3. This occurred through an enhanced binding of HIF‐2α to the 3′ region, as revealed by an electrophoretic mobility shift assay. Conversely, the promoter of TUBB3 was shown to be inactive. In addition, we observed that HIF‐1α exhibits a repressive effect on βIII‐t expression in cells cultured in normoxia. These results show that both HIF‐α isoforms have opposing effects on βIII‐t expression in GBM cells. Finally, we observed that hypoxia‐induced βIII‐t expression is well correlated with the kinetics of HIF‐2α protein stabilization. The evidence for a direct linkage between HIF‐2α and increased expression of βIII‐t by hypoxia suggests that an anti‐HIF‐2α strategy (i.e. by downregulating βIII‐t) could be of potential interest for improving the treatment of GBM.
AbstractList Glioblastoma multiforme (GBM) is the deadliest form of primary brain cancer. Several reports have indicated aberrant levels of βIII‐tubulin (βIII‐t) in human GBM. βIII‐t overexpression was linked to increasing malignancy in glial tumors and described to determine the onset of resistance to chemotherapy. Furthermore, a linkage was suggested between the induction of βIII‐t expression and hypoxia, a hallmark of GBM. We investigated the role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α in the regulation of the βIII‐t gene (TUBB3) in GBM cells cultured in either normoxia or hypoxia. We report for the first time that HIF‐2α, but not HIF‐1α, is involved in hypoxia‐induced βIII‐t expression in GBM cells. By gene‐reporter experiments and site‐directed mutagenesis, we found that two overlapping hypoxia response elements located in the 3′ UTR of the gene were involved in the activation of TUBB3. This occurred through an enhanced binding of HIF‐2α to the 3′ region, as revealed by an electrophoretic mobility shift assay. Conversely, the promoter of TUBB3 was shown to be inactive. In addition, we observed that HIF‐1α exhibits a repressive effect on βIII‐t expression in cells cultured in normoxia. These results show that both HIF‐α isoforms have opposing effects on βIII‐t expression in GBM cells. Finally, we observed that hypoxia‐induced βIII‐t expression is well correlated with the kinetics of HIF‐2α protein stabilization. The evidence for a direct linkage between HIF‐2α and increased expression of βIII‐t by hypoxia suggests that an anti‐HIF‐2α strategy (i.e. by downregulating βIII‐t) could be of potential interest for improving the treatment of GBM.
Glioblastoma multiforme (GBM) is the deadliest form of primary brain cancer. Several reports have indicated aberrant levels of βIII-tubulin (βIII-t) in human GBM. βIII-t overexpression was linked to increasing malignancy in glial tumors and described to determine the onset of resistance to chemotherapy. Furthermore, a linkage was suggested between the induction of βIII-t expression and hypoxia, a hallmark of GBM. We investigated the role of hypoxia-inducible factor (HIF)-1α and HIF-2α in the regulation of the βIII-t gene (TUBB3) in GBM cells cultured in either normoxia or hypoxia. We report for the first time that HIF-2α, but not HIF-1α, is involved in hypoxia-induced βIII-t expression in GBM cells. By gene-reporter experiments and site-directed mutagenesis, we found that two overlapping hypoxia response elements located in the 3' UTR of the gene were involved in the activation of TUBB3. This occurred through an enhanced binding of HIF-2α to the 3' region, as revealed by an electrophoretic mobility shift assay. Conversely, the promoter of TUBB3 was shown to be inactive. In addition, we observed that HIF-1α exhibits a repressive effect on βIII-t expression in cells cultured in normoxia. These results show that both HIF-α isoforms have opposing effects on βIII-t expression in GBM cells. Finally, we observed that hypoxia-induced βIII-t expression is well correlated with the kinetics of HIF-2α protein stabilization. The evidence for a direct linkage between HIF-2α and increased expression of βIII-t by hypoxia suggests that an anti-HIF-2α strategy (i.e. by downregulating βIII-t) could be of potential interest for improving the treatment of GBM.Glioblastoma multiforme (GBM) is the deadliest form of primary brain cancer. Several reports have indicated aberrant levels of βIII-tubulin (βIII-t) in human GBM. βIII-t overexpression was linked to increasing malignancy in glial tumors and described to determine the onset of resistance to chemotherapy. Furthermore, a linkage was suggested between the induction of βIII-t expression and hypoxia, a hallmark of GBM. We investigated the role of hypoxia-inducible factor (HIF)-1α and HIF-2α in the regulation of the βIII-t gene (TUBB3) in GBM cells cultured in either normoxia or hypoxia. We report for the first time that HIF-2α, but not HIF-1α, is involved in hypoxia-induced βIII-t expression in GBM cells. By gene-reporter experiments and site-directed mutagenesis, we found that two overlapping hypoxia response elements located in the 3' UTR of the gene were involved in the activation of TUBB3. This occurred through an enhanced binding of HIF-2α to the 3' region, as revealed by an electrophoretic mobility shift assay. Conversely, the promoter of TUBB3 was shown to be inactive. In addition, we observed that HIF-1α exhibits a repressive effect on βIII-t expression in cells cultured in normoxia. These results show that both HIF-α isoforms have opposing effects on βIII-t expression in GBM cells. Finally, we observed that hypoxia-induced βIII-t expression is well correlated with the kinetics of HIF-2α protein stabilization. The evidence for a direct linkage between HIF-2α and increased expression of βIII-t by hypoxia suggests that an anti-HIF-2α strategy (i.e. by downregulating βIII-t) could be of potential interest for improving the treatment of GBM.
Glioblastoma multiforme (GBM) is the deadliest form of primary brain cancer. Several reports have indicated aberrant levels of βIII‐tubulin (βIII‐t) in human GBM. βIII‐t overexpression was linked to increasing malignancy in glial tumors and described to determine the onset of resistance to chemotherapy. Furthermore, a linkage was suggested between the induction of βIII‐t expression and hypoxia, a hallmark of GBM. We investigated the role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α in the regulation of the βIII‐t gene ( TUBB3 ) in GBM cells cultured in either normoxia or hypoxia. We report for the first time that HIF‐2α, but not HIF‐1α, is involved in hypoxia‐induced βIII‐t expression in GBM cells. By gene‐reporter experiments and site‐directed mutagenesis, we found that two overlapping hypoxia response elements located in the 3′ UTR of the gene were involved in the activation of TUBB3 . This occurred through an enhanced binding of HIF‐2α to the 3′ region, as revealed by an electrophoretic mobility shift assay. Conversely, the promoter of TUBB3 was shown to be inactive. In addition, we observed that HIF‐1α exhibits a repressive effect on βIII‐t expression in cells cultured in normoxia. These results show that both HIF‐α isoforms have opposing effects on βIII‐t expression in GBM cells. Finally, we observed that hypoxia‐induced βIII‐t expression is well correlated with the kinetics of HIF‐2α protein stabilization. The evidence for a direct linkage between HIF‐2α and increased expression of βIII‐t by hypoxia suggests that an anti‐HIF‐2α strategy (i.e. by downregulating βIII‐t) could be of potential interest for improving the treatment of GBM.
Glioblastoma multiforme (GBM) is the deadliest form of primary brain cancer. Several reports have indicated aberrant levels of beta III-tubulin ( beta III-t) in human GBM. beta III-t overexpression was linked to increasing malignancy in glial tumors and described to determine the onset of resistance to chemotherapy. Furthermore, a linkage was suggested between the induction of beta III-t expression and hypoxia, a hallmark of GBM. We investigated the role of hypoxia-inducible factor (HIF)-1 alpha and HIF-2 alpha in the regulation of the beta III-t gene (TUBB3) in GBM cells cultured in either normoxia or hypoxia. We report for the first time that HIF-2 alpha , but not HIF-1 alpha , is involved in hypoxia-induced beta III-t expression in GBM cells. By gene-reporter experiments and site-directed mutagenesis, we found that two overlapping hypoxia response elements located in the 3' UTR of the gene were involved in the activation of TUBB3. This occurred through an enhanced binding of HIF-2 alpha to the 3' region, as revealed by an electrophoretic mobility shift assay. Conversely, the promoter of TUBB3 was shown to be inactive. In addition, we observed that HIF-1 alpha exhibits a repressive effect on beta III-t expression in cells cultured in normoxia. These results show that both HIF- alpha isoforms have opposing effects on beta III-t expression in GBM cells. Finally, we observed that hypoxia-induced beta III-t expression is well correlated with the kinetics of HIF-2 alpha protein stabilization. The evidence for a direct linkage between HIF-2 alpha and increased expression of beta III-t by hypoxia suggests that an anti-HIF-2 alpha strategy (i.e. by downregulating beta III-t) could be of potential interest for improving the treatment of GBM. beta III-tubulin ( beta III-t) overexpression is linked to increasing malignancy and chemoresistance in glioblastoma (GBM). We report that HIF-2 alpha is involved in hypoxia-induced beta III-t expression in GBM cells through the binding on hypoxia response elements located in the 3'UTR. HIF-1 alpha exhibits a repressive effect on beta III-t expression. An anti-HIF-2 alpha strategy could be of potential interest to improve the treatment of GBM.
Glioblastoma multiforme (GBM) is the deadliest form of primary brain cancer. Several reports have indicated aberrant levels of βIII‐tubulin (βIII‐t) in human GBM. βIII‐t overexpression was linked to increasing malignancy in glial tumors and described to determine the onset of resistance to chemotherapy. Furthermore, a linkage was suggested between the induction of βIII‐t expression and hypoxia, a hallmark of GBM. We investigated the role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α in the regulation of the βIII‐t gene (TUBB3) in GBM cells cultured in either normoxia or hypoxia. We report for the first time that HIF‐2α, but not HIF‐1α, is involved in hypoxia‐induced βIII‐t expression in GBM cells. By gene‐reporter experiments and site‐directed mutagenesis, we found that two overlapping hypoxia response elements located in the 3′ UTR of the gene were involved in the activation of TUBB3. This occurred through an enhanced binding of HIF‐2α to the 3′ region, as revealed by an electrophoretic mobility shift assay. Conversely, the promoter of TUBB3 was shown to be inactive. In addition, we observed that HIF‐1α exhibits a repressive effect on βIII‐t expression in cells cultured in normoxia. These results show that both HIF‐α isoforms have opposing effects on βIII‐t expression in GBM cells. Finally, we observed that hypoxia‐induced βIII‐t expression is well correlated with the kinetics of HIF‐2α protein stabilization. The evidence for a direct linkage between HIF‐2α and increased expression of βIII‐t by hypoxia suggests that an anti‐HIF‐2α strategy (i.e. by downregulating βIII‐t) could be of potential interest for improving the treatment of GBM. βIII‐tubulin (βIII‐t) overexpression is linked to increasing malignancy and chemoresistance in glioblastoma (GBM). We report that HIF‐2α is involved in hypoxia‐induced βIII‐t expression in GBM cells through the binding on hypoxia response elements located in the 3′UTR. HIF‐1α exhibits a repressive effect on βIII‐t expression. An anti‐HIF‐2α strategy could be of potential interest to improve the treatment of GBM.
Author Cuhna‐Alves, Leilane
Bernaudin, Myriam
Lechapt‐Zalcman, Emmanuèle
Grandval, Alexandra
Bordji, Karim
Author_xml – sequence: 1
  fullname: Bordji, Karim
– sequence: 2
  fullname: Grandval, Alexandra
– sequence: 3
  fullname: Cuhna‐Alves, Leilane
– sequence: 4
  fullname: Lechapt‐Zalcman, Emmanuèle
– sequence: 5
  fullname: Bernaudin, Myriam
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25244496$$D View this record in MEDLINE/PubMed
https://hal.science/hal-01626225$$DView record in HAL
BookMark eNqNkktuFDEQhlsoiDxgwwHAywRlgl_dYy9DlGFaGolFiMTOcrvtjJG7PdjdkNlxBA7BBcJB5hCcBPd0JguEgNq4XPr-X6WqOsz2Wt_qLHuO4BlK8droKp4hAgv8KDtAU4ontMjZ3kNOP-xnhzF-hJDklPMn2T7OMaWUFwfZ9_l65W-t_Pn1m23rXtnKaWCk6nxIJby5A8fzcjamJ6eg6jvQ-g6MNbS5OwU2Ah2jbjsrHTA-gOXWUYGtX2d9C7wByskYQVmWYPMjKbu-6p1tgb5dhaQeoPRb9o1swY2zvkp45xsJlHYuPs0eG-mifnb_HmXXs8v3F_PJ4t3b8uJ8MVGUcTxBEkKdV4yQSnNW12SqlCIM1kzVEhqU5wQXtclVgWpmUplJQyWqOB1APCVH2cnou5ROrIJtZFgLL62Yny_EUIOowAXG-WeU2OORXQX_qdexE42NQ7ey1b6PAsMUiGBE_omiglM-ZYTT_0Axw4QVPE_oi3u0rxpdP_S7220C4Aio4GMM2ghlOzkspAvSOoGgGM5HDOcjtueTJK9-k-xc_wijEf5inV7_hRSzyzdXO83LUWOkF_Im2Ciur3Aa6zCtnLMp-QXmjuVT
CitedBy_id crossref_primary_10_1186_s13550_023_01052_8
crossref_primary_10_1016_j_bbcan_2021_188607
crossref_primary_10_1016_j_jvssci_2020_09_003
crossref_primary_10_1038_s41416_022_01717_6
crossref_primary_10_3389_fcell_2021_607142
crossref_primary_10_1007_s13361_015_1270_3
crossref_primary_10_1016_j_spen_2015_03_009
crossref_primary_10_3892_or_2016_5309
crossref_primary_10_3390_ijms18071434
crossref_primary_10_3389_fcell_2022_851542
crossref_primary_10_1126_scitranslmed_aax2879
crossref_primary_10_1007_s12015_019_09942_y
crossref_primary_10_4155_fmc_2018_0163
crossref_primary_10_3390_biomedicines10050986
crossref_primary_10_1186_s13287_015_0101_6
crossref_primary_10_3892_or_2015_4404
crossref_primary_10_1016_j_drudis_2018_05_003
crossref_primary_10_3390_ijms23115991
crossref_primary_10_3390_ijms23179563
crossref_primary_10_1021_acsmedchemlett_8b00060
crossref_primary_10_1158_1535_7163_MCT_22_0066
crossref_primary_10_3390_ph18030389
crossref_primary_10_3390_cancers16112089
crossref_primary_10_1007_s00018_021_04101_4
crossref_primary_10_1016_j_niox_2019_08_008
crossref_primary_10_1517_14712598_2015_1084281
crossref_primary_10_3390_cancers11091308
crossref_primary_10_17816_MAJ83594
Cites_doi 10.1038/nrc2803
10.1158/0008-5472.CAN-07-0509
10.1093/emboj/17.11.3005
10.1215/15228517-2007-024
10.1007/s10555-007-9055-1
10.1016/j.tips.2005.11.009
10.1158/0008-5472.CAN-08-1135
10.1158/0008-5472.CAN-10-4142
10.1056/NEJMoa043330
10.1002/jcp.22813
10.1371/journal.pone.0021717
10.2174/187152011797378760
10.1158/1535-7163.MCT-07-2370
10.1182/blood-2010-10-314427
10.1016/j.freeradbiomed.2011.08.023
10.1016/j.cellsig.2009.10.004
10.1097/00005072-199311000-00013
10.1158/1078-0432.CCR-05-2715
10.1159/000339152
10.1158/0008-5472.CAN-04-3246
10.1158/0008-5472.CAN-12-1345
10.1215/15228517-2008-072
10.1038/sj.bjc.6603675
10.4161/cbt.3.11.1216
10.1128/MCB.23.24.9361-9374.2003
10.1128/MCB.25.13.5675-5686.2005
10.1002/jcp.22798
10.1038/nrc3183
10.1172/JCI0215451
10.1016/S0305-7372(03)00003-3
10.1002/hep.23597
10.1101/gad.12.2.149
10.1158/0008-5472.CAN-05-3345
10.1038/cdd.2008.21
10.1515/hsz-2012-0318
10.1371/journal.pone.0072358
10.1016/j.ccr.2006.08.026
10.1016/j.gde.2008.12.001
10.2174/138161212800626238
10.1073/pnas.0906432106
10.5858/2001-125-0613-ALOTNC
10.1038/bjc.2012.553
10.2174/138161212800626193
10.1093/annonc/mdi902
10.1002/jcp.21870
10.1158/1535-7163.MCT-05-0244
10.1016/j.ccr.2009.03.018
10.1016/j.gene.2014.03.037
10.1016/j.gene.2007.11.015
10.1096/fj.01-0125com
10.1007/BF00318141
10.1038/nrd3253
10.1016/j.tibs.2012.06.004
10.1242/jcs.035022
10.1074/jbc.M901790200
10.1158/0008-5472.CAN-09-4487
10.1091/mbc.e06-05-0419
10.1113/expphysiol.2005.030924
10.1038/nrn1408
ContentType Journal Article
Copyright 2014 FEBS
2014 FEBS.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 2014 FEBS
– notice: 2014 FEBS.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID FBQ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
7S9
L.6
1XC
DOI 10.1111/febs.13062
DatabaseName AGRIS
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Neurosciences Abstracts
AGRICOLA
AGRICOLA - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Neurosciences Abstracts
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
MEDLINE - Academic
MEDLINE
CrossRef
Neurosciences Abstracts



Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1742-4658
EndPage 5236
ExternalDocumentID oai_HAL_hal_01626225v1
25244496
10_1111_febs_13062
FEBS13062
US201600005987
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Centre National de la Recherche Scientifique (CNRS)
– fundername: University of Caen‐Basse Normandie (UCBN)
– fundername: French Ministère de l'Enseignement Supérieur et de la Recherche (MESR)
GroupedDBID ---
-DZ
-~X
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
29H
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
A8Z
AAESR
AAEVG
AAHBH
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEFU
ABEML
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACUHS
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C1A
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EAD
EAP
EAS
EAU
EBB
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EST
ESX
EX3
F00
F01
F04
F5P
FBQ
FIJ
FUBAC
G-S
G.N
GODZA
GX1
H.X
HF~
HGLYW
HH5
HZI
HZ~
IHE
IX1
J0M
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OBS
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RNS
ROL
RX1
SUPJJ
SV3
TEORI
TR2
TUS
UB1
V8K
W8V
W99
WBFHL
WBKPD
WIH
WIJ
WIK
WIN
WOHZO
WOQ
WOW
WQJ
WXI
WXSBR
WYISQ
X7M
XG1
Y6R
~IA
~KM
~WT
24P
AEUQT
AFPWT
OK1
WRC
AAYXX
AEYWJ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
ESTFP
7TK
7S9
L.6
1XC
ID FETCH-LOGICAL-c4892-1a00e5b833be98dd37ccc380d8cda0f155326df5c61d8f0d88af4a1b947ccc273
IEDL.DBID DR2
ISSN 1742-464X
1742-4658
IngestDate Fri May 09 12:13:20 EDT 2025
Fri Sep 05 17:17:09 EDT 2025
Thu Jul 10 18:19:12 EDT 2025
Mon Sep 08 10:19:12 EDT 2025
Thu Apr 03 07:03:29 EDT 2025
Tue Jul 01 03:06:42 EDT 2025
Thu Apr 24 22:57:22 EDT 2025
Wed Jan 22 16:33:39 EST 2025
Thu Apr 03 09:42:13 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 23
Keywords hypoxia
HIF-1α
βIII-tubulin
HIF-2α
glioblastoma cells
Language English
License 2014 FEBS.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4892-1a00e5b833be98dd37ccc380d8cda0f155326df5c61d8f0d88af4a1b947ccc273
Notes http://dx.doi.org/10.1111/febs.13062
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-0778-3397
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.13062
PMID 25244496
PQID 1628238695
PQPubID 23479
PageCount 17
ParticipantIDs hal_primary_oai_HAL_hal_01626225v1
proquest_miscellaneous_2000013213
proquest_miscellaneous_1694978394
proquest_miscellaneous_1628238695
pubmed_primary_25244496
crossref_citationtrail_10_1111_febs_13062
crossref_primary_10_1111_febs_13062
wiley_primary_10_1111_febs_13062_FEBS13062
fao_agris_US201600005987
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2014
PublicationDateYYYYMMDD 2014-12-01
PublicationDate_xml – month: 12
  year: 2014
  text: December 2014
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle The FEBS journal
PublicationTitleAlternate FEBS J
PublicationYear 2014
Publisher Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies
Wiley
Publisher_xml – name: Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies
– name: Wiley
References 2010; 10
2011; 117
2002; 110
2004; 3
2008; 7
2011; 11
2004; 5
2005; 65
2012; 18
2008; 32
2013; 8
2012; 12
2005; 25
2009; 11
2010; 22
1998; 17
2006; 20
1991; 265
2006; 66
2006; 27
2011; 71
2009; 122
2007; 9
2008; 68
2013; 394
2001; 15
2009; 284
2010; 70
2009; 19
2007; 67
1998; 12
2009; 15
2010; 9
2007; 26
2012; 83
2007; 18
2005; 352
2006; 12
2013; 108
2006; 10
2005; 90
2008; 409
2008; 15
2012; 37
2007; 96
2011; 6
2012; 227
2001; 125
1999; 9
2013; 73
2011; 51
1993; 52
2009; 221
2005; 4
2003; 29
2013
2005; 16
2010; 51
2003; 23
2014; 542
2009; 106
e_1_2_8_28_1
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_5_1
e_1_2_8_7_1
e_1_2_8_9_1
e_1_2_8_20_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_64_1
e_1_2_8_62_1
e_1_2_8_41_1
e_1_2_8_60_1
e_1_2_8_17_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_59_1
e_1_2_8_15_1
e_1_2_8_57_1
Scigliano S (e_1_2_8_38_1) 2008; 32
Glantz MJ (e_1_2_8_16_1) 1999; 9
Mitic G (e_1_2_8_43_1) 2013
e_1_2_8_32_1
e_1_2_8_55_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_53_1
e_1_2_8_51_1
e_1_2_8_30_1
e_1_2_8_29_1
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_27_1
e_1_2_8_48_1
e_1_2_8_2_1
e_1_2_8_4_1
e_1_2_8_6_1
Chang SM (e_1_2_8_3_1) 2006; 20
e_1_2_8_8_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_23_1
e_1_2_8_44_1
e_1_2_8_63_1
e_1_2_8_40_1
e_1_2_8_61_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_37_1
e_1_2_8_58_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_56_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_54_1
e_1_2_8_52_1
e_1_2_8_50_1
References_xml – volume: 18
  start-page: 2778
  year: 2012
  end-page: 2792
  article-title: Tubulins as therapeutic targets in cancer: from bench to bedside
  publication-title: Curr Pharm Des
– volume: 108
  start-page: 82
  year: 2013
  end-page: 90
  article-title: Altered TUBB3 expression contributes to the epothilone response of mitotic cells
  publication-title: Br J Cancer
– volume: 11
  start-page: 719
  year: 2011
  end-page: 728
  article-title: Targeting βIII‐tubulin in glioblastoma multiforme: from cell biology and histopathology to cancer therapeutics
  publication-title: Anticancer Agents Med Chem
– volume: 542
  start-page: 173
  year: 2014
  end-page: 181
  article-title: Sox9 and Hif‐2a regulate TUBB3 gene expression and affect ovarian cancer aggressiveness
  publication-title: Gene
– volume: 51
  start-page: 2183
  year: 2010
  end-page: 2192
  article-title: Roles of hypoxia‐inducible factor‐1alpha (HIF‐1alpha) versus HIF‐2alpha in the survival of hepatocellular tumor spheroids
  publication-title: Hepatol Baltim Md
– volume: 11
  start-page: 158
  year: 2009
  end-page: 166
  article-title: Sagopilone crosses the blood‐brain barrier in vivo to inhibit brain tumor growth and metastases
  publication-title: Neuro‐Oncol
– volume: 15
  start-page: 678
  year: 2008
  end-page: 685
  article-title: The role of hypoxia‐inducible factors in tumorigenesis
  publication-title: Cell Death Differ
– volume: 12
  start-page: 2774
  year: 2006
  end-page: 2779
  article-title: Class III beta‐tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients
  publication-title: Clin Cancer Res Off J Am Assoc Cancer Res
– volume: 122
  start-page: 1055
  year: 2009
  end-page: 1057
  article-title: HIF at a glance
  publication-title: J Cell Sci
– volume: 12
  start-page: 9
  year: 2012
  end-page: 22
  article-title: HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
  publication-title: Nat Rev Cancer
– volume: 66
  start-page: 5641
  year: 2006
  end-page: 5647
  article-title: Role of ETS transcription factors in the hypoxia‐inducible factor‐2 target gene selection
  publication-title: Cancer Res
– volume: 18
  start-page: 2793
  year: 2012
  end-page: 2803
  article-title: Novel drugs targeting microtubules: the role of epothilones
  publication-title: Curr Pharm Des
– volume: 284
  start-page: 16767
  year: 2009
  end-page: 16775
  article-title: Genome‐wide association of hypoxia‐inducible factor (HIF)‐1alpha and HIF‐2alpha DNA binding with expression profiling of hypoxia‐inducible transcripts
  publication-title: J Biol Chem
– volume: 71
  start-page: 4015
  year: 2011
  end-page: 4027
  article-title: The hypoxia‐associated factor switches cells from HIF‐1α‐ to HIF‐2α‐dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion
  publication-title: Cancer Res
– volume: 68
  start-page: 9212
  year: 2008
  end-page: 9220
  article-title: Hypoxia‐inducible factor‐2alpha correlates to distant recurrence and poor outcome in invasive breast cancer
  publication-title: Cancer Res
– volume: 8
  start-page: e72358
  year: 2013
  article-title: STAT3 or USF2 contributes to HIF target gene specificity
  publication-title: PLoS ONE
– volume: 106
  start-page: 21306
  year: 2009
  end-page: 21311
  article-title: Human cancers converge at the HIF‐2alpha oncogenic axis
  publication-title: Proc Natl Acad Sci USA
– volume: 20
  start-page: E4
  year: 2006
  article-title: Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme
  publication-title: Neurosurg Focus
– volume: 16
  start-page: iv14
  issue: Suppl. 4
  year: 2005
  end-page: iv19
  article-title: Biomarkers predictive for clinical efficacy of taxol‐based chemotherapy in advanced breast cancer
  publication-title: Ann Oncol Off J Eur Soc Med Oncol ESMO
– volume: 6
  start-page: e21717
  year: 2011
  article-title: Specific β‐tubulin isotypes can functionally enhance or diminish epothilone B sensitivity in non‐small cell lung cancer cells
  publication-title: PLoS ONE
– volume: 67
  start-page: 9356
  year: 2007
  end-page: 9363
  article-title: Class III beta‐tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer
  publication-title: Cancer Res
– volume: 22
  start-page: 349
  year: 2010
  end-page: 356
  article-title: Oxygen‐sensing under the influence of nitric oxide
  publication-title: Cell Signal
– volume: 3
  start-page: 1137
  year: 2004
  end-page: 1146
  article-title: Neuronal‐associated microtubule proteins class III beta‐tubulin and MAP2c in neuroblastoma: role in resistance to microtubule‐targeted drugs
  publication-title: Mol Cancer Ther
– volume: 265
  start-page: 73
  year: 1991
  end-page: 81
  article-title: Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme
  publication-title: Cell Tissue Res
– volume: 409
  start-page: 100
  year: 2008
  end-page: 108
  article-title: Hypoxia induces class III beta‐tubulin gene expression by HIF‐1alpha binding to its 3′ flanking region
  publication-title: Gene
– volume: 9
  start-page: 412
  year: 2007
  end-page: 423
  article-title: Antiangiogenic and anti‐invasive effects of sunitinib on experimental human glioblastoma
  publication-title: Neuro‐Oncol
– volume: 32
  start-page: 69
  year: 2008
  end-page: 77
  article-title: Measurement of hypoxia using invasive oxygen‐sensitive electrode, pimonidazole binding and 18F‐FDG uptake in anaemic or erythropoietin‐treated mice bearing human glioma xenografts
  publication-title: Int J Oncol
– volume: 221
  start-page: 505
  year: 2009
  end-page: 513
  article-title: Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta‐tubulin
  publication-title: J Cell Physiol
– volume: 96
  start-page: 1284
  year: 2007
  end-page: 1292
  article-title: Target gene selectivity of hypoxia‐inducible factor‐alpha in renal cancer cells is conveyed by post‐DNA‐binding mechanisms
  publication-title: Br J Cancer
– volume: 70
  start-page: 4995
  year: 2010
  end-page: 5003
  article-title: betaIII‐tubulin is a multifunctional protein involved in drug sensitivity and tumorigenesis in non‐small cell lung cancer
  publication-title: Cancer Res
– volume: 83
  start-page: 1
  year: 2012
  end-page: 9
  article-title: Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single‐institution phase I/II trial
  publication-title: Oncology
– volume: 25
  start-page: 5675
  year: 2005
  end-page: 5686
  article-title: Contrasting properties of hypoxia‐inducible factor 1 (HIF‐1) and HIF‐2 in von Hippel‐Lindau‐associated renal cell carcinoma
  publication-title: Mol Cell Biol
– volume: 9
  start-page: 27
  year: 1999
  end-page: 33
  article-title: The role of paclitaxel in the treatment of primary and metastatic brain tumors
  publication-title: Semin Radiat Oncol
– volume: 27
  start-page: 17
  year: 2006
  end-page: 24
  article-title: Use of P‐glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs
  publication-title: Trends Pharmacol Sci
– volume: 352
  start-page: 987
  year: 2005
  end-page: 996
  article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
  publication-title: N Engl J Med
– volume: 26
  start-page: 225
  year: 2007
  end-page: 239
  article-title: Hypoxia in cancer: significance and impact on clinical outcome
  publication-title: Cancer Metastasis Rev
– volume: 23
  start-page: 9361
  year: 2003
  end-page: 9374
  article-title: Differential roles of hypoxia‐inducible factor 1alpha (HIF‐1alpha) and HIF‐2alpha in hypoxic gene regulation
  publication-title: Mol Cell Biol
– volume: 12
  start-page: 149
  year: 1998
  end-page: 162
  article-title: Cellular and developmental control of O homeostasis by hypoxia‐inducible factor 1 alpha
  publication-title: Genes Dev
– volume: 10
  start-page: 413
  year: 2006
  end-page: 423
  article-title: Recruitment of HIF‐1alpha and HIF‐2alpha to common target genes is differentially regulated in neuroblastoma: HIF‐2alpha promotes an aggressive phenotype
  publication-title: Cancer Cell
– volume: 7
  start-page: 2070
  year: 2008
  end-page: 2079
  article-title: Proteomic characterization of cytoskeletal and mitochondrial class III beta‐tubulin
  publication-title: Mol Cancer Ther
– volume: 51
  start-page: 1882
  year: 2011
  end-page: 1892
  article-title: Opposite effects of HIF‐1α and HIF‐2α on the regulation of IL‐8 expression in endothelial cells
  publication-title: Free Radic Biol Med
– volume: 73
  start-page: 6230
  year: 2013
  end-page: 6242
  article-title: Tumor cells upregulate normoxic HIF‐1α in response to doxorubicin
  publication-title: Cancer Res
– volume: 125
  start-page: 613
  year: 2001
  end-page: 624
  article-title: Aberrant localization of the neuronal class III beta‐tubulin in astrocytomas
  publication-title: Arch Pathol Lab Med
– volume: 227
  start-page: 1034
  year: 2012
  end-page: 1041
  article-title: Class III β‐tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer
  publication-title: J Cell Physiol
– volume: 9
  start-page: 790
  year: 2010
  end-page: 803
  article-title: Microtubule‐binding agents: a dynamic field of cancer therapeutics
  publication-title: Nat Rev Drug Discov
– volume: 65
  start-page: 2277
  year: 2005
  end-page: 2286
  article-title: Targeted replacement of hypoxia‐inducible factor‐1alpha by a hypoxia‐inducible factor‐2alpha knock‐in allele promotes tumor growth
  publication-title: Cancer Res
– volume: 110
  start-page: 1309
  year: 2002
  end-page: 1318
  article-title: Transport of paclitaxel (Taxol) across the blood‐brain barrier in vitro and in vivo
  publication-title: J Clin Invest
– volume: 29
  start-page: 297
  year: 2003
  end-page: 307
  article-title: Tumour hypoxia, chemotherapeutic resistance and hypoxia‐related therapies
  publication-title: Cancer Treat Rev
– volume: 90
  start-page: 791
  year: 2005
  end-page: 797
  article-title: Hypoxia‐inducible factor as a physiological regulator
  publication-title: Exp Physiol
– volume: 394
  start-page: 529
  year: 2013
  end-page: 539
  article-title: Noninvasive assessment of hypoxia with 3‐[18F]‐fluoro‐1‐(2‐nitro‐1‐imidazolyl)‐2‐propanol ([18F]‐FMISO): a PET study in two experimental models of human glioma
  publication-title: Biol Chem
– volume: 15
  start-page: 2445
  year: 2001
  end-page: 2453
  article-title: HIF‐1 is expressed in normoxic tissue and displays an organ‐specific regulation under systemic hypoxia
  publication-title: FASEB J Off Publ Fed Am Soc Exp Biol
– volume: 10
  start-page: 194
  year: 2010
  end-page: 204
  article-title: Microtubules and resistance to tubulin‐binding agents
  publication-title: Nat Rev Cancer
– start-page: 3431
  year: 2013
  article-title: betaIII‐tubulin in glioblastoma: an emerging multifactorial survival factor role in chemotherapy response and tumor formation
  publication-title: Proc 104th Annu Meet Am Assoc Cancer Res
– volume: 4
  start-page: 2001
  year: 2005
  end-page: 2007
  article-title: Class III beta‐tubulin expression in tumor cells predicts response and outcome in patients with non‐small cell lung cancer receiving paclitaxel
  publication-title: Mol Cancer Ther
– volume: 117
  start-page: e207
  year: 2011
  end-page: e217
  article-title: High‐resolution genome‐wide mapping of HIF‐binding sites by ChIP‐seq
  publication-title: Blood
– volume: 37
  start-page: 364
  year: 2012
  end-page: 372
  article-title: Passing the baton: the HIF switch
  publication-title: Trends Biochem Sci
– volume: 18
  start-page: 4528
  year: 2007
  end-page: 4542
  article-title: The N‐terminal transactivation domain confers target gene specificity of hypoxia‐inducible factors HIF‐1alpha and HIF‐2alpha
  publication-title: Mol Biol Cell
– volume: 5
  start-page: 437
  year: 2004
  end-page: 448
  article-title: HIF1 and oxygen sensing in the brain
  publication-title: Nat Rev Neurosci
– volume: 17
  start-page: 3005
  year: 1998
  end-page: 3015
  article-title: HIF‐1 alpha is required for solid tumor formation and embryonic vascularization
  publication-title: EMBO J
– volume: 52
  start-page: 655
  year: 1993
  end-page: 666
  article-title: Differential localization of class III, beta‐tubulin isotype and calbindin‐D28k defines distinct neuronal types in the developing human cerebellar cortex
  publication-title: J Neuropathol Exp Neurol
– volume: 227
  start-page: 514
  year: 2012
  end-page: 524
  article-title: Functional regulation of HIF‐1α under normoxia–is there more than post‐translational regulation?
  publication-title: J Cell Physiol
– volume: 19
  start-page: 60
  year: 2009
  end-page: 66
  article-title: Hypoxia inducible factor‐2alpha: a critical mediator of aggressive tumor phenotypes
  publication-title: Curr Opin Genet Dev
– volume: 15
  start-page: 501
  year: 2009
  end-page: 513
  article-title: Hypoxia‐inducible factors regulate tumorigenic capacity of glioma stem cells
  publication-title: Cancer Cell
– ident: e_1_2_8_21_1
  doi: 10.1038/nrc2803
– ident: e_1_2_8_7_1
  doi: 10.1158/0008-5472.CAN-07-0509
– ident: e_1_2_8_48_1
  doi: 10.1093/emboj/17.11.3005
– ident: e_1_2_8_36_1
  doi: 10.1215/15228517-2007-024
– ident: e_1_2_8_25_1
  doi: 10.1007/s10555-007-9055-1
– ident: e_1_2_8_15_1
  doi: 10.1016/j.tips.2005.11.009
– ident: e_1_2_8_58_1
  doi: 10.1158/0008-5472.CAN-08-1135
– volume: 20
  start-page: E4
  year: 2006
  ident: e_1_2_8_3_1
  article-title: Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme
  publication-title: Neurosurg Focus
– ident: e_1_2_8_60_1
  doi: 10.1158/0008-5472.CAN-10-4142
– ident: e_1_2_8_2_1
  doi: 10.1056/NEJMoa043330
– ident: e_1_2_8_11_1
  doi: 10.1002/jcp.22813
– ident: e_1_2_8_12_1
  doi: 10.1371/journal.pone.0021717
– ident: e_1_2_8_23_1
  doi: 10.2174/187152011797378760
– ident: e_1_2_8_10_1
  doi: 10.1158/1535-7163.MCT-07-2370
– ident: e_1_2_8_54_1
  doi: 10.1182/blood-2010-10-314427
– ident: e_1_2_8_45_1
  doi: 10.1016/j.freeradbiomed.2011.08.023
– ident: e_1_2_8_49_1
  doi: 10.1016/j.cellsig.2009.10.004
– ident: e_1_2_8_5_1
  doi: 10.1097/00005072-199311000-00013
– ident: e_1_2_8_40_1
  doi: 10.1158/1078-0432.CCR-05-2715
– ident: e_1_2_8_18_1
  doi: 10.1159/000339152
– ident: e_1_2_8_32_1
  doi: 10.1158/0008-5472.CAN-04-3246
– ident: e_1_2_8_51_1
  doi: 10.1158/0008-5472.CAN-12-1345
– ident: e_1_2_8_17_1
  doi: 10.1215/15228517-2008-072
– ident: e_1_2_8_55_1
  doi: 10.1038/sj.bjc.6603675
– ident: e_1_2_8_8_1
  doi: 10.4161/cbt.3.11.1216
– ident: e_1_2_8_29_1
  doi: 10.1128/MCB.23.24.9361-9374.2003
– ident: e_1_2_8_31_1
  doi: 10.1128/MCB.25.13.5675-5686.2005
– ident: e_1_2_8_50_1
  doi: 10.1002/jcp.22798
– ident: e_1_2_8_33_1
  doi: 10.1038/nrc3183
– ident: e_1_2_8_14_1
  doi: 10.1172/JCI0215451
– ident: e_1_2_8_24_1
  doi: 10.1016/S0305-7372(03)00003-3
– ident: e_1_2_8_52_1
  doi: 10.1002/hep.23597
– volume: 32
  start-page: 69
  year: 2008
  ident: e_1_2_8_38_1
  article-title: Measurement of hypoxia using invasive oxygen‐sensitive electrode, pimonidazole binding and 18F‐FDG uptake in anaemic or erythropoietin‐treated mice bearing human glioma xenografts
  publication-title: Int J Oncol
– ident: e_1_2_8_47_1
  doi: 10.1101/gad.12.2.149
– ident: e_1_2_8_56_1
  doi: 10.1158/0008-5472.CAN-05-3345
– ident: e_1_2_8_26_1
  doi: 10.1038/cdd.2008.21
– ident: e_1_2_8_37_1
  doi: 10.1515/hsz-2012-0318
– ident: e_1_2_8_57_1
  doi: 10.1371/journal.pone.0072358
– volume: 9
  start-page: 27
  year: 1999
  ident: e_1_2_8_16_1
  article-title: The role of paclitaxel in the treatment of primary and metastatic brain tumors
  publication-title: Semin Radiat Oncol
– ident: e_1_2_8_61_1
  doi: 10.1016/j.ccr.2006.08.026
– ident: e_1_2_8_59_1
  doi: 10.1016/j.gde.2008.12.001
– ident: e_1_2_8_19_1
  doi: 10.2174/138161212800626238
– ident: e_1_2_8_62_1
  doi: 10.1073/pnas.0906432106
– ident: e_1_2_8_6_1
  doi: 10.5858/2001-125-0613-ALOTNC
– ident: e_1_2_8_20_1
  doi: 10.1038/bjc.2012.553
– ident: e_1_2_8_22_1
  doi: 10.2174/138161212800626193
– ident: e_1_2_8_41_1
  doi: 10.1093/annonc/mdi902
– ident: e_1_2_8_4_1
  doi: 10.1002/jcp.21870
– ident: e_1_2_8_42_1
  doi: 10.1158/1535-7163.MCT-05-0244
– ident: e_1_2_8_63_1
  doi: 10.1016/j.ccr.2009.03.018
– ident: e_1_2_8_35_1
  doi: 10.1016/j.gene.2014.03.037
– ident: e_1_2_8_34_1
  doi: 10.1016/j.gene.2007.11.015
– ident: e_1_2_8_46_1
  doi: 10.1096/fj.01-0125com
– ident: e_1_2_8_64_1
  doi: 10.1007/BF00318141
– ident: e_1_2_8_9_1
  doi: 10.1038/nrd3253
– ident: e_1_2_8_39_1
  doi: 10.1016/j.tibs.2012.06.004
– ident: e_1_2_8_27_1
  doi: 10.1242/jcs.035022
– ident: e_1_2_8_53_1
  doi: 10.1074/jbc.M901790200
– start-page: 3431
  year: 2013
  ident: e_1_2_8_43_1
  article-title: betaIII‐tubulin in glioblastoma: an emerging multifactorial survival factor role in chemotherapy response and tumor formation
  publication-title: Proc 104th Annu Meet Am Assoc Cancer Res
– ident: e_1_2_8_13_1
  doi: 10.1158/0008-5472.CAN-09-4487
– ident: e_1_2_8_44_1
  doi: 10.1091/mbc.e06-05-0419
– ident: e_1_2_8_28_1
  doi: 10.1113/expphysiol.2005.030924
– ident: e_1_2_8_30_1
  doi: 10.1038/nrn1408
SSID ssj0035499
Score 2.2930326
Snippet Glioblastoma multiforme (GBM) is the deadliest form of primary brain cancer. Several reports have indicated aberrant levels of βIII‐tubulin (βIII‐t) in human...
Glioblastoma multiforme (GBM) is the deadliest form of primary brain cancer. Several reports have indicated aberrant levels of βIII-tubulin (βIII-t) in human...
Glioblastoma multiforme (GBM) is the deadliest form of primary brain cancer. Several reports have indicated aberrant levels of beta III-tubulin ( beta III-t)...
SourceID hal
proquest
pubmed
crossref
wiley
fao
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 5220
SubjectTerms Base Sequence
Basic Helix-Loop-Helix Transcription Factors - genetics
Basic Helix-Loop-Helix Transcription Factors - physiology
Binding Sites
brain
Brain Neoplasms - metabolism
Brain Neoplasms - pathology
Cell Hypoxia
Cell Line, Tumor
cultured cells
drug therapy
gel electrophoresis
genes
Glioblastoma - metabolism
Glioblastoma - pathology
glioblastoma cells
HIF‐1α
HIF‐2α
Humans
hypoxia
hypoxia-inducible factor 1
Hypoxia-Inducible Factor 1, alpha Subunit - genetics
Hypoxia-Inducible Factor 1, alpha Subunit - physiology
Life Sciences
Molecular Sequence Data
neoplasms
normoxia
promoter regions
Promoter Regions, Genetic
response elements
RNA, Small Interfering - genetics
site-directed mutagenesis
tubulin
Tubulin - genetics
βIII‐tubulin
Title Hypoxia‐inducible factor‐2α (HIF‐2α), but not HIF‐1α, is essential for hypoxic induction of class III β‐tubulin expression in human glioblastoma cells
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Ffebs.13062
https://www.ncbi.nlm.nih.gov/pubmed/25244496
https://www.proquest.com/docview/1628238695
https://www.proquest.com/docview/1694978394
https://www.proquest.com/docview/2000013213
https://hal.science/hal-01626225
Volume 281
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwELVKX-CFSws0XKrhIkRRU21ix0kkXpbS1S63B8pK-1JFtmO3K5akYhPU8sQn8BH8QPmQ_Qi-hLGzWSiXSvASRdbYsuMz9owzPkPI_UBrjvtK6keRUD5TJvaFYdqn3OQxi-JQuktiL1_x_pA9G0WjJfK4vQvT8EMsDtysZrj12iq4kNOflNxoObW5jN0CHFBuifOfvl5wR1Hr-DS3IUOfcTaac5PaMJ4fVU_tRueMKPF5YCMifzc3T1uvbvvpXSJ7bcebqJO3W3Ult9THXzgd_3dkl8nFuV0K3QZIV8iSLlbIardAn_zdMTwAFynqjuBXyPntNkvcKvnSPz4sj8bi26fP6N3XaiwnGpokPlgUzk7gYX_Qa143NkHWFRRlBU1ZMDvZhPEULH95gUvNBNCEhgPXogLXnsUNlAaUtfJhMBjA7CvWrGppQ-hBH80DeQsUB5dwEPYn41KiOPZcgP0xMb1Khr2dN9t9f575wVcsSUM_EJ2OjmRCqdRpkuc0VkrRpGNTLYmOsbmOQp6bSPEgTwwWJwgwEciUWUG0yK6R5aIs9BoBSoWOU0EjrhF7OpSKmkSiEWgCluuYemSjRUCm5rToNjvHJGvdIzsdmZsOj9xbyB42ZCB_lFpDIGViH1fpbLgbWg4_x4OTxB65i-ha1LXU3v3ui8yWoVTIcXH9EHjkTgu-DCfTfidR6LLG5jk6yDThaXSWTGqTBtKU_V0mdP90aBjg6K836F70KYzQ4GMp98gjh9EzBpr1dp7surcb_yJ8k1zAb8KamKBbZLl6X-vbaNlVch01ePB83enxdzzwT50
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwELWgPJQXLi3Q5WouQhQ11SZ2bo9L6SoL2z7QrrRvke3Y7YolqdgEtTzxCXwEP1A-ZD-CL2HGyQbKpRK8RJE1tuJ4PD5jj88Q8sTVOoB1JXZ8XyiHKxM6wnDtsMBkIfdDT9pLYju7QTLir8b-uInNwbswNT9Eu-GGM8Paa5zguCH90yw3Ws4wmTFa4EsckAb6Xi_ftOxRDF2f-j6k5_CAjxt2Ugzk-VH3zHp00YgCnocYE_k74DyLX-0C1L9aZ1mdWd5CjDt5u1mVclN9_IXV8b_7do1caaAp7dW6dJ1c0PkKWe3l4Ja_O6FPqQ0WtbvwK2R5a5EobpV8SU6OiuOJ-PbpMzj4lZrIqaZ1Hh8o8uan9Fky6Nev6xtUViXNi5LWZe78dINOZhQpzHOwNlMKKJoe2hYVte2h6tDCUIVAnw4GAzr_CjXLSmIUPdXHTSxvDuLU5hykB9NJIUEcvlxQPJuY3SCj_vb-VuI0yR8cxaPYc1zR7WpfRoxJHUdZxkKlFIu6mG1JdA2mO_KCzPgqcLPIQHEEOiZcGXMUBFB2kyzlRa7XCGVM6DAWzA80qJ_2pGImkoADjcszHbIOWV-oQKoaZnRM0DFNFx4SDkdqh6NDHreyRzUfyB-l1kCTUnEAhjod7XlI42epcKKwQx6BerV1kd076Q1TLAMpLwD7-sHtkIcL7UthMPE_iVwXFTQfgI_MoiD2z5OJMW8gi_nfZTx7rMM8F3p_q1bv9ps8HzAfj4MOeW6V9JyOpv3tF3v27fa_CD8gy8n-zjAdDnZf3yGX4f_wOkToLlkq31f6HgC9Ut630_k7GcpSww
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwELVKkYAXLi3Q5WouQhQ11SZ2nETipZSudqFUiLLSvqDIdux2xZKs2AS1PPEJfAQ_UD5kP4IvYcbZLJRLJXiJImts2fF4fMYZnyHkvm-MgH0l8cJQao9rG3nScuMxYbOIh1Gg3CWxFzui2-fPBuFggTxu7sLU_BDzAzdcGc5e4wIfZ_anRW6NmmAuYzTAp7kAKIGQ6NWcPIqh51Nfhww8LvhgRk6KcTw_6h7bjk5ZWcBzH0Mif8ebx-Gr2386F8ibpud12Mnb9apU6_rjL6SO_zu0i-T8DJjSjVqTLpEFky-R5Y0cnPJ3h_QBdaGi7gx-iZzdbNLELZMv3cNxcTCU3z59Bve-0kM1MrTO4gNFwfSIPuz2OvXr6hpVVUnzoqR1mT89WqPDCUUC8xxszYgChqb7rkVNXXuoOLSwVCPMp71ej06_Qs2yUhhDT83BLJI3B3HqMg7SvdGwUCAOPZcU_0xMLpN-Z-v1ZtebpX7wNI-TwPNlu21CFTOmTBJnGYu01ixuY64l2baY7CgQmQ218LPYQnEMGiZ9lXAUBEh2hSzmRW5WCGVMmiiRLBQGlM8ESjMbK0CB1ueZiViLrDYakOoZLzqm5xiljX-E05G66WiRe3PZcc0G8kepFVCkVO6BmU77uwGS-DkinDhqkbugXfO6yO3d3dhOsQykAgHW9YPfInca5UthMvE7ydwUFTQvwENmsUjCk2QSzBrIEv53mcD91GGBD6O_Wmv3vE9BCIiPJ6JFHjkdPWGgaWfrya57u_YvwrfJmZdPO-l2b-f5dXIOPg-v44NukMXyfWVuAsor1S23mL8D8RhRcg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypoxia%E2%80%90inducible+factor%E2%80%902%CE%B1+%28HIF%E2%80%902%CE%B1%29%2C+but+not+HIF%E2%80%901%CE%B1%2C+is+essential+for+hypoxic+induction+of+class+III+%CE%B2%E2%80%90tubulin+expression+in+human+glioblastoma+cells&rft.jtitle=The+FEBS+journal&rft.au=Bordji%2C+Karim&rft.au=Grandval%2C+Alexandra&rft.au=Cuhna%E2%80%90Alves%2C+Leilane&rft.au=Lechapt%E2%80%90Zalcman%2C+Emmanu%C3%A8le&rft.date=2014-12-01&rft.issn=1742-464X&rft.eissn=1742-4658&rft.volume=281&rft.issue=23&rft.spage=5220&rft.epage=5236&rft_id=info:doi/10.1111%2Ffebs.13062&rft.externalDBID=10.1111%252Ffebs.13062&rft.externalDocID=FEBS13062
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-464X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-464X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-464X&client=summon